NASDAQ · Analyst Forecast

Lantern Pharma Inc. (LTRN) Stock Forecast & Price Target

$0.37 NASDAQ: LTRN Market Cap $5.45M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Lantern Pharma Inc. (LTRN), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Lantern Pharma Inc., the average estimate for 2030 earnings per share is −$2.38; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$0$0$01
2026$1.95M$1.95M$1.95M1
2027$14.60M$14.60M$14.60M1
2028$33.80M$33.80M$33.80M1
2029$0$0$01
2030$0$0$01

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$1.67−$1.67−$1.671
2026−$1.63−$1.63−$1.631
2027−$2.02−$2.02−$2.021
2028−$2.11−$2.11−$2.111
2029−$2.20−$2.20−$2.201
2030−$2.38−$2.38−$2.381

Lantern Pharma Inc. (LTRN) forecast — frequently asked questions

What are analysts forecasting for Lantern Pharma Inc.'s earnings?

The average analyst estimate for Lantern Pharma Inc. (LTRN) earnings per share in 2030 is -2.38, with individual estimates between -2.38 and -2.38.

How much revenue is Lantern Pharma Inc. expected to make?

Analysts forecast Lantern Pharma Inc. (LTRN) revenue of $0 in 2030, based on 1 published estimates.

How many analysts cover LTRN?

1 analyst contribute estimates for Lantern Pharma Inc. (LTRN). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.